{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:53:15Z","timestamp":1785891195316,"version":"3.56.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004895","name":"European Social Fund Plus","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.rmed.2026.108942","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T15:33:13Z","timestamp":1780759993000},"page":"108942","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["CT assessment of body composition and lung evolution in cystic fibrosis after Elexacaftor-Tezacaftor-Ivacaftor: A cohort study"],"prefix":"10.1016","volume":"260","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3285-7194","authenticated-orcid":false,"given":"Virginia","family":"Soria-Utrilla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7834-1145","authenticated-orcid":false,"given":"Ana","family":"Pi\u00f1ar-Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Jos\u00e9","family":"S\u00e1nchez-Torralvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1539-057X","authenticated-orcid":false,"given":"Antonio","family":"Adarve-Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8727-3231","authenticated-orcid":false,"given":"Marina","family":"Padial","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"Jim\u00e9nez-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Esther","family":"Quintana-Gallego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6912-7400","authenticated-orcid":false,"given":"Casilda","family":"Olveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Victoria","family":"Gir\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Olveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7460-5422","authenticated-orcid":false,"given":"Pedro Pablo","family":"Garc\u00eda-Luna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10059","key":"10.1016\/j.rmed.2026.108942_bib1","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1016\/S0140-6736(16)00576-6","article-title":"Cystic fibrosis","volume":"388","author":"Elborn","year":"2016","journal-title":"Lancet."},{"issue":"12","key":"10.1016\/j.rmed.2026.108942_bib2","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1016\/j.clnu.2023.10.015","article-title":"A prospective study to assess the impact of a novel CFTR therapy combination on body composition in patients with cystic fibrosis with F508del mutation","volume":"42","author":"Knott-Torcal","year":"2023","journal-title":"Clin. Nutr."},{"issue":"1","key":"10.1016\/j.rmed.2026.108942_bib3","first-page":"19","article-title":"Actualizaci\u00f3n en nutrici\u00f3n en la fibrosis qu\u00edstica","author":"Contreras Bol\u00edvar","year":"2019","journal-title":"Nutricion Clinica En Medicina"},{"issue":"7","key":"10.1016\/j.rmed.2026.108942_bib4","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.jand.2020.03.014","article-title":"Effect of CFTR modulators on anthropometric parameters in individuals with cystic fibrosis: an evidence analysis center systematic review","volume":"121","author":"Bailey","year":"2021","journal-title":"J. Acad. Nutr. Diet."},{"issue":"2","key":"10.1016\/j.rmed.2026.108942_bib5","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jcf.2021.11.012","article-title":"Effect of elexacaftor-tezacaftor-ivacaftor on body weight and metabolic parameters in adults with cystic fibrosis","volume":"21","author":"Petersen","year":"2022","journal-title":"J. Cyst. Fibros."},{"issue":"2","key":"10.1016\/j.rmed.2026.108942_bib6","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.clnu.2023.12.017","article-title":"ESPEN-ESPGHAN-ECFS guideline on nutrition care for cystic fibrosis","volume":"43","author":"Wilschanski","year":"2024","journal-title":"Clin. Nutr."},{"issue":"2","key":"10.1016\/j.rmed.2026.108942_bib7","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jcf.2018.02.006","article-title":"ECFS best practice guidelines: the 2018 revision","volume":"17","author":"Castellani","year":"2018","journal-title":"J. Cyst. Fibros."},{"issue":"5","key":"10.1016\/j.rmed.2026.108942_bib8","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jada.2008.02.020","article-title":"Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review","volume":"108","author":"Stallings","year":"2008","journal-title":"J. Am. Diet. Assoc."},{"issue":"12","key":"10.1016\/j.rmed.2026.108942_bib9","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1017\/S0007114525103760","article-title":"Dietary protein intake and overall diet quality in adults with cystic fibrosis following elexacaftor\/tezacaftor\/ivacaftor therapy","volume":"133","author":"Morgan","year":"2025","journal-title":"Br. J. Nutr."},{"issue":"4","key":"10.1016\/j.rmed.2026.108942_bib10","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3390\/jimaging11040124","article-title":"Evolution of lung disease studied by computed tomography in adults with cystic fibrosis treated with elexacaftor\/tezacaftor\/ivacaftor","volume":"11","author":"Hern\u00e1ndez-Mu\u00f1iz","year":"2025","journal-title":"J Imaging"},{"issue":"19","key":"10.1016\/j.rmed.2026.108942_bib11","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.3390\/nu16193293","article-title":"Impact of elexacaftor-tezacaftor-ivacaftor therapy on body composition, dietary intake, biomarkers, and quality of life in people with cystic fibrosis: a prospective observational study","volume":"16","author":"Hevilla","year":"2024","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.rmed.2026.108942_bib13","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.3390\/nu14061216","article-title":"The changing landscape of nutrition in cystic fibrosis: the emergence of overweight and obesity","volume":"14","author":"Bailey","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.rmed.2026.108942_bib14","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.nut.2018.03.052","article-title":"Cystic fibrosis, body composition, and health outcomes: a systematic review","volume":"55\u201356","author":"Calella","year":"2018","journal-title":"Nutrition"},{"issue":"1","key":"10.1016\/j.rmed.2026.108942_bib15","doi-asserted-by":"crossref","first-page":"9465","DOI":"10.1038\/s41598-024-59622-2","article-title":"Elexacaftor\/tezacaftor\/ivacaftor influences body composition in adults with cystic fibrosis: a fully automated CT-based analysis","volume":"14","author":"Westh\u00f6lter","year":"2024","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.rmed.2026.108942_bib16","doi-asserted-by":"crossref","first-page":"W32","DOI":"10.1097\/RTI.0000000000000517","article-title":"Are we missing the opportunity to measure muscle mass on computed tomography thorax?","volume":"36","author":"Bryl","year":"2021","journal-title":"J. Thorac. Imag."},{"issue":"1","key":"10.1016\/j.rmed.2026.108942_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-29825-5","article-title":"Skeletal muscle cutoff values for sarcopenia diagnosis using T10 to L5 measurements in a healthy US population","volume":"8","author":"Derstine","year":"2018","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.rmed.2026.108942_bib18","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s41747-023-00340-1","article-title":"Association between thoracic and third lumbar CT-derived muscle mass and density in Caucasian patients without chronic disease: a proof-of-concept study","volume":"7","author":"Brath","year":"2023","journal-title":"Eur Radiol Exp"},{"issue":"18","key":"10.1016\/j.rmed.2026.108942_bib19","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.3390\/nu17182940","article-title":"Integrating imaging and nutrition: chest CT muscle analysis in adults with cystic fibrosis","volume":"17","author":"Soria-Utrilla","year":"2025","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.rmed.2026.108942_bib20","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1148\/radiology.179.3.2027992","article-title":"Cystic fibrosis: scoring system with thin-section CT","volume":"179","author":"Bhalla","year":"1991","journal-title":"Radiology"},{"issue":"8","key":"10.1016\/j.rmed.2026.108942_bib21","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0300-2896(01)75101-0","article-title":"[SEPAR (Spanish society of pneumology and thoracic surgery) guidelines. Guideline for diagnosis and treatment of respiratory involvements in cystic fibrosis]","volume":"37","author":"M\u00e1iz","year":"2001","journal-title":"Arch. Bronconeumol."},{"issue":"4","key":"10.1016\/j.rmed.2026.108942_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/medsci13040284","article-title":"Impact of elexacaftor\u2013tezacaftor\u2013ivacaftor on muscle composition in cystic fibrosis: an AI-Assisted chest CT-Based body composition analysis","volume":"13","author":"Welsner","year":"2025","journal-title":"Med. Sci."},{"key":"10.1016\/j.rmed.2026.108942_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2024.112425","article-title":"Impact of CFTR modulator therapy on body composition as assessed by thoracic computed tomography: a Follow-Up study","author":"Navas-Moreno","year":"2024","journal-title":"Nutrition"},{"issue":"3","key":"10.1016\/j.rmed.2026.108942_bib24","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1067\/mpd.2000.107891","article-title":"Longitudinal relationship among growth, nutritional status, and pulmonary function in children with cystic fibrosis: analysis of the cystic fibrosis foundation national CF patient registry","volume":"137","author":"Zemel","year":"2000","journal-title":"J. Pediatr."},{"issue":"10","key":"10.1016\/j.rmed.2026.108942_bib25","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1136\/thorax.56.10.746","article-title":"Wasting as an independent predictor of mortality in patients with cystic fibrosis","volume":"56","author":"Sharma","year":"2001","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2026.108942_bib26","article-title":"The global burden of overweight-obesity and its association with economic status, benefiting from STEPs survey of WHO member states: a meta-analysis","volume":"46","author":"Islam","year":"2024","journal-title":"Prev. Med. Rep."},{"issue":"6","key":"10.1016\/j.rmed.2026.108942_bib27","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.jcf.2023.06.010","article-title":"Body mass index and nutritional intake following elexacaftor\/Tezacaftor\/Ivacaftor modulator therapy in adults with cystic fibrosis","volume":"22","author":"Caley","year":"2023","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.rmed.2026.108942_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2024.1477674","article-title":"Increased fat mass and obesity risk after elexacaftor-tezacaftor-ivacaftor therapy in young adults with cystic fibrosis","volume":"11","author":"Merino S\u00e1nchez-Ca\u00f1ete","year":"2024","journal-title":"Front. Nutr."},{"issue":"8","key":"10.1016\/j.rmed.2026.108942_bib29","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41430-025-01589-y","article-title":"A systematic review of the impact of elexacaftor\/tezacaftor\/ivacaftor on body composition in people with cystic fibrosis","volume":"79","author":"Kinsey","year":"2025","journal-title":"Eur. J. Clin. Nutr."},{"issue":"9","key":"10.1016\/j.rmed.2026.108942_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/ppul.71280","article-title":"Elexacaftor\/tezacaftor\/ivacaftor effect on bone density and body composition: a retrospective analysis","volume":"60","author":"Trost","year":"2025","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.rmed.2026.108942_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1161116","article-title":"Comparison of computed tomography and dual-energy X-ray absorptiometry in the evaluation of body composition in patients with obesity","volume":"14","author":"Palmas","year":"2023","journal-title":"Front. Endocrinol."},{"issue":"8","key":"10.1016\/j.rmed.2026.108942_bib32","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1080\/07853890.2018.1511918","article-title":"Implications of low muscle mass across the continuum of care: a narrative review","volume":"50","author":"Prado","year":"2018","journal-title":"Ann. Med."},{"issue":"8","key":"10.1016\/j.rmed.2026.108942_bib33","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1002\/ppul.26485","article-title":"Impact of elexacaftor-tezacaftor-ivacaftor on lung disease in cystic fibrosis","volume":"58","author":"Gushue","year":"2023","journal-title":"Pediatr. Pulmonol."},{"issue":"4","key":"10.1016\/j.rmed.2026.108942_bib34","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1183\/23120541.01248-2024","article-title":"Respiratory infections after elexacaftor\/tezacaftor\/ivacaftor treatment in people with cystic fibrosis: analysis of the european cystic fibrosis society patient registry","volume":"11","author":"Pollak","year":"2025","journal-title":"ERJ Open Res"},{"issue":"9","key":"10.1016\/j.rmed.2026.108942_bib35","doi-asserted-by":"crossref","DOI":"10.1148\/rg.240008","article-title":"Update on the role of chest imaging in cystic fibrosis","volume":"44","author":"Bugenhagen","year":"2024","journal-title":"Radiographics"},{"issue":"4","key":"10.1016\/j.rmed.2026.108942_bib36","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1513\/pats.200708-128ET","article-title":"Imaging studies in emphysema","volume":"5","author":"Friedman","year":"2008","journal-title":"Proc. Am. Thorac. Soc."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611126003100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611126003100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:32:23Z","timestamp":1785889943000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611126003100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":35,"alternative-id":["S0954611126003100"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2026.108942","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CT assessment of body composition and lung evolution in cystic fibrosis after Elexacaftor-Tezacaftor-Ivacaftor: A cohort study","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2026.108942","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108942"}}